{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:42:58Z","timestamp":1780710178853,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-022-00737-7","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T20:02:38Z","timestamp":1660680158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Simulation of Intraluminal Performance of Lipophilic Weak Bases in Fasted Healthy Adults Using DDDPlusTM"],"prefix":"10.1208","volume":"24","author":[{"given":"Marina","family":"Statelova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Kourentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"737_CR1","doi-asserted-by":"crossref","unstructured":"Amidon GL, Lennern\u00e4s H, Shah VP, Crison JR. A Theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413\u201320.","DOI":"10.1023\/A:1016212804288"},{"issue":"1","key":"737_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1208\/s12248-008-9020-0","volume":"10","author":"MS Ku","year":"2008","unstructured":"Ku MS. Use of the biopharmaceutical classification system in early drug development. AAPS J. 2008;10(1):208\u201312.","journal-title":"AAPS J"},{"key":"737_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejps.2019.04.013","volume":"134","author":"M Vertzoni","year":"2019","unstructured":"Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N, et al. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. Eur J Pharm Sci. 2019;134:153\u201375.","journal-title":"Eur J Pharm Sci"},{"key":"737_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105117","volume":"142","author":"M Braeckmans","year":"2020","unstructured":"Braeckmans M, Brouwers J, Masuy I, Servais C, Tack J, Augustijns P. The influence of gastric motility on the intraluminal behavior of fosamprenavir. Eur J Pharm Sci. 2020;142:105117.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"737_CR5","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1016\/j.xphs.2016.03.008","volume":"105","author":"S Geboers","year":"2016","unstructured":"Geboers S, Stappaerts J, Mols R, Snoeys J, Tack J, Annaert P, et al. The effect of food on the intraluminal behavior of abiraterone acetate in man. J Pharm Sci. 2016;105(9):2974\u201381.","journal-title":"J Pharm Sci"},{"issue":"12","key":"737_CR6","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","volume":"28","author":"D Psachoulias","year":"2011","unstructured":"Psachoulias D, Vertzoni M, Goumas K, Kalioras V, Beato S, Butler J, et al. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Pharm Res. 2011;28(12):3145\u201358.","journal-title":"Pharm Res"},{"key":"737_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejpb.2016.10.027","volume":"112","author":"J Van Den Abeele","year":"2017","unstructured":"Van Den Abeele J, Brouwers J, Tack J, Augustijns P. Exploring the link between gastric motility and intragastric drug distribution in man. Eur J Pharm Biopharm. 2017;112:75\u201384.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"737_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jps.24647","volume":"105","author":"J Van Den Abeele","year":"2016","unstructured":"Van Den Abeele J, Brouwers J, Mattheus R, Tack J, Augustijns P. Gastrointestinal behavior of weakly acidic BCS class II drugs in man - case study of diclofenac potassium. J Pharm Sci. 2016;105(2):687\u201396.","journal-title":"J Pharm Sci"},{"issue":"1","key":"737_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","volume":"57","author":"ES Kostewicz","year":"2014","unstructured":"Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, et al. PBPK models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;57(1):300\u201321.","journal-title":"Eur J Pharm Sci"},{"key":"737_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejpb.2018.12.010","volume":"136","author":"J Butler","year":"2019","unstructured":"Butler J, Hens B, Vertzoni M, Brouwers J, Berben P, Dressman J, et al. In vitro models for the prediction of in vivo performance of oral dosage forms: recent progress from partnership through the IMI OrBiTo collaboration. Eur J Pharm Biopharm. 2019;136:70\u201383.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"737_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jphp.12951","volume":"71","author":"PJ O\u2019Dwyer","year":"2018","unstructured":"O\u2019Dwyer PJ, Litou C, Box KJ, Dressman JB, Kostewicz ES, Kuentz M, et al. In vitro methods to assess drug precipitation in the fasted small intestine \u2013 a PEARRL review. J Pharm Pharmacol. 2018;71(4):536\u201356.","journal-title":"J Pharm Pharmacol"},{"key":"737_CR12","doi-asserted-by":"crossref","unstructured":"Sj\u00f6gren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, Brewster M, et al. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects. Eur J Pharm Sci. 2014;57:99\u2013151.","DOI":"10.1016\/j.ejps.2014.02.010"},{"key":"737_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106100","volume":"172","author":"CG Wilson","year":"2022","unstructured":"Wilson CG, Aarons L, Augustijns P, Brouwers J, Darwich AS, De Waal T, et al. Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective. Eur J Pharm Sci. 2022;172:106100.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"737_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1211\/0022357022511","volume":"56","author":"ES Kostewicz","year":"2010","unstructured":"Kostewicz ES, Wunderlich M, Brauns U, Becker R, Bock T, Dressman JB. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol. 2010;56(1):43\u201351.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"737_CR15","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1002\/jps.22236","volume":"99","author":"SR Carino","year":"2010","unstructured":"Carino SR, Sperry DC, Hawley M. Relative bioavailability of three different solid forms of PNU-141659 as determined with the artificial stomach-duodenum model. J Pharm Sci. 2010;99(9):3923\u201330.","journal-title":"J Pharm Sci"},{"issue":"4","key":"737_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/acs.molpharmaceut.6b01063","volume":"14","author":"K Matsui","year":"2017","unstructured":"Matsui K, Tsume Y, Takeuchi S, Searls A, Amidon GL. Utilization of gastrointestinal simulator, an in vivo predictive dissolution methodology, coupled with computational approach to forecast oral absorption of dipyridamole. Mol Pharm. 2017;14(4):1181\u20139.","journal-title":"Mol Pharm"},{"issue":"6","key":"737_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4172\/jbb.1000162","volume":"5","author":"Y Tsume","year":"2013","unstructured":"Tsume Y, Amidon GL, Takeuchi S. Dissolution effect of gastric and intestinal pH fora BCS class II drug, pioglitazone: new in vitro dissolution system to predict in vivo dissolution. J Bioequivalence Bioavailab. 2013;5(6):224\u20137.","journal-title":"J Bioequivalence Bioavailab"},{"key":"737_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejps.2015.11.012","volume":"82","author":"A Kourentas","year":"2016","unstructured":"Kourentas A, Vertzoni M, Stavrinoudakis N, Symillidis A, Brouwers J, Augustijns P, et al. An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation. Eur J Pharm Sci. 2016;82:106\u201314.","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"737_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijpharm.2016.10.018","volume":"515","author":"A Kourentas","year":"2016","unstructured":"Kourentas A, Vertzoni M, Symillides M, Hens B, Brouwers J, Augustijns P, et al. In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT. Int J Pharm. 2016;515(1\u20132):352\u20138.","journal-title":"Int J Pharm"},{"issue":"4","key":"737_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-018-0231-8","volume":"20","author":"A Kourentas","year":"2018","unstructured":"Kourentas A, Vertzoni M, Barmpatsalou V, Augustijns P, Beato S, Butler J, et al. The BioGIT system: a valuable in vitro tool to assess the impact of dose and formulation on early exposure to low solubility drugs after oral administration. AAPS J. 2018;20(4):1\u201312.","journal-title":"AAPS J"},{"issue":"7","key":"737_CR21","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1208\/s12249-018-1059-3","volume":"19","author":"F Kesisoglou","year":"2018","unstructured":"Kesisoglou F, Vertzoni M, Reppas C. Physiologically based absorption modeling of salts of weak bases based on data in hypochlorhydric and achlorhydric biorelevant media. AAPS PharmSciTech. 2018;19(7):2851\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"737_CR22","first-page":"1","volume-title":"DDDPlus V6 Manual","author":"SimulationsPlus Inc","year":"2018","unstructured":"SimulationsPlus Inc. DDDPlus V6 Manual; 2018. p. 1\u2013226."},{"issue":"4","key":"737_CR23","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.xphs.2018.11.034","volume":"108","author":"SM Pathak","year":"2019","unstructured":"Pathak SM, Schaefer KJ, Jamei M, Turner DB. Biopharmaceutic IVIVE\u2014mechanistic modeling of single- and two-phase in vitro experiments to obtain drug-specific parameters for incorporation into PBPK models. J Pharm Sci. 2019;108(4):1604\u201318.","journal-title":"J Pharm Sci"},{"issue":"12","key":"737_CR24","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1021\/acs.molpharmaceut.7b00406","volume":"14","author":"SM Pathak","year":"2017","unstructured":"Pathak SM, Ruff A, Kostewicz ES, Patel N, Turner DB, Jamei M. Model-based analysis of biopharmaceutic experiments to improve mechanistic oral absorption modeling: an integrated in vitro in vivo extrapolation perspective using ketoconazole as a model drug. Mol Pharm. 2017;14(12):4305\u201320.","journal-title":"Mol Pharm"},{"key":"737_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejps.2016.12.017","volume":"100","author":"A Ruff","year":"2017","unstructured":"Ruff A, Fiolka T, Kostewicz ES. Prediction of ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling. Eur J Pharm Sci. 2017;100:42\u201355.","journal-title":"Eur J Pharm Sci"},{"key":"737_CR26","volume-title":"Therapeutic Drugs","author":"CI Dollery","year":"1999","unstructured":"Dollery CI. Therapeutic Drugs: Churchill Livingstone; 1999. (Therapeutic Drugs)"},{"issue":"5","key":"737_CR27","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1021\/mp100049m","volume":"7","author":"JH Fagerberg","year":"2010","unstructured":"Fagerberg JH, Tsinman O, Sun N, Tsinman K, Avdeef A, Bergstr\u00f6m CAS. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media. Mol Pharm. 2010;7(5):1419\u201330.","journal-title":"Mol Pharm"},{"issue":"1","key":"737_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1016062224568","volume":"13","author":"SD Mithani","year":"1995","unstructured":"Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Estimation of the increasi in solubility of drugs as function of bile salt concentration. Pharm Res. 1995;13(1):163\u20137.","journal-title":"Pharm Res"},{"key":"737_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","volume":"93","author":"C Markopoulos","year":"2015","unstructured":"Markopoulos C, Andreas CJ, Vertzoni M, Dressman J, Reppas C. In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media. Eur J Pharm Biopharm. 2015;93:173\u201382.","journal-title":"Eur J Pharm Biopharm"},{"key":"737_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/bdd.1800","volume":"33","author":"Y Tsume","year":"2012","unstructured":"Tsume Y, Langguth P, Garcia-Arieta A, Amidon GL. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: in silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen a. Biopharm Drug Dispos. 2012;33:366\u201377.","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"737_CR31","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s11095-016-1882-8","volume":"33","author":"C Litou","year":"2016","unstructured":"Litou C, Vertzoni M, Goumas C, Vasdekis V, Xu W, Kesisoglou F, et al. Characteristics of the human upper gastrointestinal contents in the fasted state under hypo- and a-chlorhydric gastric conditions under conditions of typical drug \u2013 drug interaction studies. Pharm Res. 2016;33(6):1399\u2013412.","journal-title":"Pharm Res"},{"issue":"2","key":"737_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jps.24603","volume":"105","author":"D Riethorst","year":"2016","unstructured":"Riethorst D, Mols R, Duchateau G, Tack J, Brouwers J, Augustijns P. Characterization of human duodenal fluids in fasted and fed state conditions. J Pharm Sci. 2016;105(2):673\u201381.","journal-title":"J Pharm Sci"},{"key":"737_CR33","volume":"162","author":"Z Vinarov","year":"2021","unstructured":"Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, et al. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2021 Jul;162:105812.","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"737_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejpb.2020.02.014","volume":"150","author":"B Hens","year":"2020","unstructured":"Hens B, Masuy I, Deloose E, Mols R, Tack J, Augustijns P. Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects. Eur J Pharm Biopharm. 2020;150:66\u201376.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"737_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","volume":"50","author":"J Walravens","year":"2011","unstructured":"Walravens J, Brouwers J, Spriet I, Tack J, Annaert P, Augustijns P. Effect of pH and comedication on gastrointestinal absorption of posaconazole. Clin Pharmacokinet. 2011;50(11):725\u201334.","journal-title":"Clin Pharmacokinet"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-022-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-022-00737-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-022-00737-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:36:08Z","timestamp":1676421368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-022-00737-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1208\/s12248-022-00737-7","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"89"}}